Table 2.
Overview of the changes in professional duties since the COVID-19 outbreak (N = 942)
| n (%) | ||||
|---|---|---|---|---|
| Change in professional duties | ||||
| Yes | 525 (60) | |||
| No | 344 (40) | |||
| Work routine has returned to pre-COVID-19 situation | Disagree 441 (51) |
Neither 148 (17) |
Agree 280 (32) |
|
| Nature of change in duties, n = 579 | ||||
| Scope of clinical work | Increased | No change | Decreased | N/A |
| Direct patient care | 135 (26) | 200 (38) | 190 (36) | 54 |
| Remote consultations | 472 (89) | 40 (8) | 16 (3) | 51 |
| Inpatient work | 111 (22) | 205 (41) | 179 (36) | 84 |
| COVID-19 inpatient work | 137 (40) | 164 (48) | 39 (12) | 239 |
| Covering other oncology patients | 132 (31) | 230 (54) | 64 (15) | 153 |
| Covering non-oncology specialties | 120 (32) | 226 (59) | 34 (9) | 199 |
| Virtual MDT/tumour board meetings | 450 (84) | 59 (11) | 25 (5) | 45 |
| Remote meetings | 506 (92) | 29 (5) | 15 (3) | 29 |
| Working hours and shift patterns | Increased | No change | Decreased | N/A |
| Overall hours of work | 221 (38) | 198 (34) | 156 (27) | 4 |
| Out-of-hours work in hospital | 183 (36) | 197 (39) | 128 (25) | 71 |
| Hours working from home | 362 (66) | 156 (28) | 31 (6) | 30 |
| Weekend shifts | 87 (19) | 295 (65) | 72 (16) | 125 |
| Overnight shifts | 61 (15) | 277 (70) | 57 (14) | 184 |
| Clinical trial and research activity | Increased | No change | Decreased | N/A |
| Clinical trial activity | 34 (7) | 132 (27) | 320 (66) | 93 |
| Research (non-clinical trials) activity | 79 (16) | 139 (28) | 275 (56) | 86 |
| COVID-19 related research | 202 (59) | 120 (35) | 22 (6) | 235 |
| Redeployed | ||||
| Yes | 45 (5.2) | |||
| Partially | 140 (16.0) | |||
| No | 687 (78.8) | |||
| Duration of redeployment, n = 185 | ||||
| <4 weeks | 61 (33.0) | |||
| 1-3 months | 77 (41.6) | |||
| >3 months | 44 (23.8) | |||
| Prefer not to say | 3 (1.6) | |||
MDT, multidisciplinary team.